These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7796946)

  • 1. Safety aspects of oral poliovirus vaccine campaigns.
    Hovi T
    Dev Biol Stand; 1995; 84():137-44. PubMed ID: 7796946
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Poliomyelitis in the Federal Republic of Germany. A retrospective study of 1973 (author's transl)].
    Neumann-Haefelin D; Newmann-Haefelin C; Baumeister HG; Knocke KW; Petersen EE; Haas R
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2597-602. PubMed ID: 4373221
    [No Abstract]   [Full Text] [Related]  

  • 4. Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.
    Kinnunen E; Junttila O; Haukka J; Hovi T
    Am J Epidemiol; 1998 Jan; 147(1):69-73. PubMed ID: 9440401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against poliomyelitis].
    Cellesi C; Rossolini A
    Pediatr Med Chir; 1984; 6(1):13-5. PubMed ID: 6099548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain.
    Avellón A; Cabrerizo M; de Miguel T; Pérez-Breña P; Tenorio A; Pérez JL; de Aragón MV; Trallero G
    Emerg Infect Dis; 2008 Nov; 14(11):1807-9. PubMed ID: 18976579
    [No Abstract]   [Full Text] [Related]  

  • 7. Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign.
    Uhari M; Rantala H; Niemelä M
    Lancet; 1989 Aug; 2(8660):440-1. PubMed ID: 2569613
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on the oral poliomyelitis vaccine (Sabin) -- associated cases of acute persisting spinal paralysis.
    Biberi-Moroeanu S; Muntiu A
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):355-68. PubMed ID: 757664
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine].
    Más Lago P; Díaz J; Díaz Gonzalez M; Goyenechea Hernández A; Barrio Olivera J; Fonseca Quintana M; Morier Díaz L; Sarmiento Pérez L; Palomera Puente R
    Rev Cubana Med Trop; 2005; 57(2):111-9. PubMed ID: 17966580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On convulsive reactions following oral vaccination against polio (author's transl)].
    Ehrengut W; Ehrengut-Lange J
    Klin Padiatr; 1979 May; 191(3):261-70. PubMed ID: 572444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and electroencephalographic studies of subjects with the West syndrome appearing after poliomyelitis vaccination].
    Marchesi GF; Quattrini A
    Riv Neurol; 1976; 46(5):377-82. PubMed ID: 1025680
    [No Abstract]   [Full Text] [Related]  

  • 12. [Virological and clinical study of morbid manifestations connected with anti-poliomyelitis vaccination with the oral Sabin vaccine].
    Marzetti G; Bertolini L; Midulla M
    Minerva Pediatr; 1967 Dec; 19(50):2236-45. PubMed ID: 5304534
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential use of viral genomic markers in estimating the neurovirulence of oral poliomyelitis vaccine (OPV): regulatory aspects.
    Fenyves A
    Dev Biol Stand; 1993; 78():157-9. PubMed ID: 8388826
    [No Abstract]   [Full Text] [Related]  

  • 15. [Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
    Gouandjika I; Rakoto Andrianarivelo M; Akoua-Koffi C; Zeller H; Ehouman A; Morvan JM
    Bull Soc Pathol Exot; 2000 Jul; 93(3):198-201. PubMed ID: 11030057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paralytic polio in an adult female following OPV vaccination of her infant.
    Blain JG; Osterman JW; Baghdadllan H; Lambert L
    Can Commun Dis Rep; 1993 Aug; 19(15):118-9. PubMed ID: 8220290
    [No Abstract]   [Full Text] [Related]  

  • 17. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why has polio eradication program failed in India.
    Paul Y
    Indian Pediatr; 2008 May; 45(5):381-8. PubMed ID: 18515926
    [No Abstract]   [Full Text] [Related]  

  • 19. Polio endgame. The exit strategy.
    Roberts L
    Science; 2004 Mar; 303(5666):1969-71. PubMed ID: 15044782
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral poliomyelitis vaccination: why should transmission of vaccine viruses to unvaccinated infants be avoided if possible?].
    Wiersbitzky S
    Kinderarztl Prax; 1993 May; 61(3):120-1. PubMed ID: 8392122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.